Inotiv, Inc. to Participate in May Investor Conferences
May 19 2023 - 8:33AM
Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or
“Inotiv”), a leading contract research organization
specializing in nonclinical and analytical drug discovery and
development services and research models and related products and
services, announced today its participation in the following
investor conferences:
- Benchmark Healthcare House
Call Conference (Virtual)One-on-one
meetings: May 23, 2023
- Craig-Hallum Institutional Investor Conference
(Minneapolis, MN)One-on-one and small group
meetings: May 31, 2023
A copy of the presentation slides to be used at
these events will be posted under the “Investor Relations” tab of
the Company’s web site at
https://www.inotivco.com/
About the CompanyInotiv, Inc. is a leading
contract research organization dedicated to providing nonclinical
and analytical drug discovery and development services and research
models and related products and services. The Company’s products
and services focus on bringing new drugs and medical devices
through the discovery and preclinical phases of development, all
while increasing efficiency, improving data, and reducing the cost
of taking new drugs to market. Inotiv is committed to supporting
discovery and development objectives as well as helping researchers
realize the full potential of their critical R&D projects, all
while working together to build a healthier and safer world.
Further information about Inotiv can be found here:
https://www.inotivco.com/.
This release contains forward-looking statements
that are subject to risks and uncertainties including, but not
limited to, risks and uncertainties related to the impact of recent
events related to NHP matters on the Company’s business,
operations, results, financial condition, cash flows, and assets,
the Company’s ability to comply with covenants under its credit
agreement, Company’s ability to reduce its legal and third party
fees, changes in the market and demand for the Company’s products
and services, the development, marketing and sales of products and
services, changes in technology, industry and regulatory standards,
the timing of acquisitions and the successful closing, integration
and business and financial impact thereof, governmental
regulations, inspections and investigations, claims, investigations
and litigation against or involving the Company, its business
and/or its industry, the impact of site closures and
consolidations, expansion and related efforts, and various other
market and operating risks, including those detailed in the
Company's filings with the U.S. Securities and Exchange
Commission.
Company Contact |
Investor Relations |
Inotiv, Inc. |
The Equity Group Inc. |
Beth A. Taylor, Chief Financial Officer |
Devin Sullivan |
(765) 497-8381 |
dsullivan@equityny.com |
btaylor@inotivco.com |
|
Inotiv (NASDAQ:NOTV)
Historical Stock Chart
From Apr 2024 to May 2024
Inotiv (NASDAQ:NOTV)
Historical Stock Chart
From May 2023 to May 2024